APHP - Charles Foix Hospital
Ivry-sur-Seine, 94200, France
NCT Number: NCT03560648
The CHRONOS project aims to provide a device to detect earlier the motor decline, by developing a precise quantitative device measuring "Motor Functional Age" (MFA) of young, middle-aged and old people, thus preventing future functional motor loss for healthy aging. The MFA might be different from the Chronological Age (CA), depending on lifestyle, physical activity, and medical condition. Thus, this device will permit monitoring, adaptation and new design of a variety of personalized therapies for healthy aging including physical exercise, medication and nutritional interventions to reduce the MFA toward or less than the CA. The device combines data processing software that estimates the MFA by assessing muscle aging using a non-invasive multichannel electromyographical technique coupled to accelerometry sensors for motion evaluation. These data will provide with a built-in clinical database of subjects from different age categories (25-75 years old).
Looking for future studies?
Notify Me25 year–75 year
All sexes
Interventional
Not applicable
Ivry-sur-Seine, 94200, France
Background:
Aging is accompanied by sarcopenia, defined by a loss in muscle mass (starting from the age of 25) and strength/function, leading to a decline in mobility. This functional motor decline is an increasing health problem with impairing functional independence and quality of life among seniors. Furthermore, a sedentary lifestyle reinforced by an abusive use of modern technology (videogames, transportation and communication) and poor dietary habits (often rich in sugar and fats and poor in high quality proteins) are more common in younger demographics than ever before. These unhealthy habits lead to premature muscle aging, sarcopenia and future functional motor loss.
Methods to easily and rapidly assess muscle quality in multiple clinical settings and with minimal patient burden are needed.
Moreover, an individual's CA, taken solely, is rarely a reliable index of an individual's ability to perform specific physical task. The proposed MFA concept is innovative since it precisely expresses the motor abilities through a sensitive screening of muscle activation using a recent HD-sEMG (High density-surface electromyogram) technique that is, by far, more robust, precise and representative than the classical single bipolar technique.
Aim and Objectives:
In the CHRONOS project, a device using HD-sEMG technology actually devoted to research actions only, even though CE-certified, will be designed by testing and combining data allowing one to assess the muscle activation efficiency and motion capacity (accelerometry sensors), as a function of CA.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Main inclusion criteria
Main exclusion Criteria
HD-sEMG and accelerometer data will be collected by Mobita 32® (TMSi) device.
Time frame: Day 0
HD-sEMG data will be correlated to Skeletal Mass Muscle Index, handgrip strength and muscle echography data.
Time frame: Day 0
Accelerometer data will be correlated to Skeletal Mass Muscle Index, handgrip strength and muscle echography data.
Time frame: Day 0
Dual-energy x-ray absorptiometry (DEXA) is the imaging technique recommended for the diagnosis of sarcopenia. It gives minimal irradiation and gives an adequate estimate of the appendicular muscle mass (ALM). By dividing the ALM by the size in centimeters, we obtain the Skeletal Mass Muscle Index (SMI). SMI values below 2 standard deviations from the mean point towards sarcopenia.
Time frame: Day 0
By placing a dynamometer in the patient's hand and asking him to apply maximum pressure to it, the muscular strength of the extremities of the limbs is estimated.
Time frame: Day 0
Walking speed evaluates the muscular performance. The seated patient must walk a distance of 4 meters as quickly as possible without the help of a third party. It has been shown that there is a non-linear relationship between walking speed and muscle strength.
Time frame: Day 0
A battery of tests combining walking speed on 4 meters, sit-to-stand test and tandem balance test giving a physical performance score
Time frame: Day 0
Dual-energy x-ray absorptiometry (DEXA) is the imaging technique recommended for bone mineral density measure
Time frame: Day 0
Time frame: Day 0
Walking speed and distance evaluates the muscular performance. The seated patient must walk during 6minutes as quickly as possible without the help of a third party.
Time frame: Day 0
IPAQ assesses physical activity undertaken across a comprehensive set of domains including:a. leisure time physical activity; b. domestic and gardening (yard) activities; c. work-related physical activity; d. transport-related physical activity. Two types of scoring: continuous score (sum of MET-minutes/week, reflecting the intensity of physical activity) and categorical score (low/moderate/high level of physical activity) with criteria based on MET-minutes/week and type of reported physical activity (moderate, vigorous intensities).
Time frame: Day 0
Time in seconds
Time frame: Day 7
Physical activity assessed objectively by actimetry during 1 week
Time frame: Day 7
Sleep-wake duration assessed objectively by actimetry during 1 week
Time frame: Day 0
The sarcopenia stage will be assessed according to the European Working Group on Sarcopenia in Older People (EWGSOP) definition: "non sarcopenia", "pre-sarcopenia" and "sarcopenia"
Assistance Publique - Hôpitaux de Paris
Other
Innovative Device for the Evaluation of the "Motor Functional Age": How Old is Your Muscle?
Acronym: CHRONOS
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03404427
Dyssomnias, Healthy Volunteers
Poitiers, Vienne, France
View Trial DetailsNCT05447078
Healthy Volunteers, Infections
Jackson, Mississippi, United States
View Trial DetailsNCT07513532
Healthy Volunteers
Seattle, Washington, United States
View Trial DetailsNCT07090655
Healthy Volunteers
Brisbane, Australia
View Trial Details